Ferran Vall-Llovera

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Alex Bataller, Ana Garrido, Francisca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Montserrat Arnan, Mar Tormo, Susana Vives, María Paz Queipo de Llano, Rosa Coll, David Gallardo, Ferran Vall-Llovera, Lourdes Escoda, Antonio Garcia-Guiñon, Olga Salamero, Maria Antonia Sampol, Brayan M Merchan, Joan Bargay, Sandra Castaño-Díez, Daniel Esteban, Marta Garrote, Andrea Rivero, Pablo Mozas, Mònica López-Guerra, Marta Pratcorona, Lurdes Zamora, Dolors Costa, Maria Rozman, Josep F Nomdedéu, Dolors Colomer, Salut Brunet, Jorge Sierra, Aleksandra Holowiecka
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood advances 6 (4) (2022)
Jorge Labrador-Gomez, Miriam Saiz-Rodriguez, Dunia de Miguel, Almudena de Laiglesia, Carlos Rodríguez-Medina, María Belén Vidriales, Manuel Pérez-Encinas, María José Sánchez-Sánchez, Rebeca Cuello, Alicia Roldán Pérez, Susana Vives, Gonzalo Benzo-Callejo, Mercedes Colorado, María García-Fortes, María José Sayas, Carmen Olivier, Isabel Recio, Diego Conde-Royo, Álvaro Bienert-García, María Vahi, Carmen Muñoz-García, Cristina Seri-Merino, María Del Mar Tormo Díaz, Ferran Vall-Llovera, Maria Angeles Foncillas, David Martínez-Cuadrón, Miguel Angel Sanz, Pau Montesinos
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience. Cancers 14 (7) (2022)

Ferran Vall-Llovera.css-eqlu8i{font-size:small;padding-left:4px;}